EZETROL

Ezetrol Adverse Events Reported to the FDA Over Time

How are Ezetrol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ezetrol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ezetrol is flagged as the suspect drug causing the adverse event.

Most Common Ezetrol Adverse Events Reported to the FDA

What are the most common Ezetrol adverse events reported to the FDA?

Myalgia	48 (3.66%)
Fatigue	43 (3.27%)
Dyspnoea	39 (2.97%)
Paraesthesia	39 (2.97%)
Atrial Fibrillation	37 (2.82%)
Dizziness	36 (2.74%)
Blood Creatine Phosphokinase Increa...	33 (2.51%)
Cardiac Murmur	29 (2.21%)
Venous Pressure Jugular Increased	28 (2.13%)
Ventricular Tachycardia	28 (2.13%)
Feeling Abnormal	26 (1.98%)
	Show More
Oedema Peripheral	26 (1.98%)
Oedema	21 (1.6%)
Left Ventricular Dysfunction	19 (1.45%)
Drug Interaction	15 (1.14%)
Alanine Aminotransferase Increased	14 (1.07%)
Rhabdomyolysis	13 (.99%)
Chest Pain	12 (.91%)
Muscle Spasms	12 (.91%)
Aspartate Aminotransferase Increase...	11 (.84%)
Bulbar Palsy	11 (.84%)
Dysphagia	11 (.84%)
Gamma-glutamyltransferase Increased	11 (.84%)
Ageusia	10 (.76%)
Anosmia	10 (.76%)
Arthralgia	10 (.76%)
Dry Eye	10 (.76%)
Lip Swelling	10 (.76%)
Nausea	10 (.76%)
Cardiac Arrest	9 (.69%)
Dissociation	9 (.69%)
Glossodynia	9 (.69%)
Liver Function Test Abnormal	9 (.69%)
Pyrexia	9 (.69%)
Tracheitis	9 (.69%)
C-reactive Protein Increased	8 (.61%)
Dyspnoea Exertional	8 (.61%)
Organising Pneumonia	8 (.61%)
Renal Failure Acute	8 (.61%)
Speech Disorder	8 (.61%)
Swollen Tongue	8 (.61%)
Abdominal Pain	7 (.53%)
Cough	7 (.53%)
Encephalopathy	7 (.53%)
Eye Pruritus	7 (.53%)
Gait Disturbance	7 (.53%)
Renal Failure	7 (.53%)
Vomiting	7 (.53%)
Asthenia	6 (.46%)
Blood Bilirubin Increased	6 (.46%)
Blood Lactate Dehydrogenase Increas...	6 (.46%)
Cardiac Fibrillation	6 (.46%)
Cheilitis	6 (.46%)
Condition Aggravated	6 (.46%)
Jaundice	6 (.46%)
Seasonal Allergy	6 (.46%)
Ventricular Dysfunction	6 (.46%)
Blood Alkaline Phosphatase Increase...	5 (.38%)
Blood Creatinine Increased	5 (.38%)
Blood Triglycerides Increased	5 (.38%)
Death	5 (.38%)
Gastrointestinal Pain	5 (.38%)
Granulomatous Liver Disease	5 (.38%)
Hallucination, Auditory	5 (.38%)
Hepatitis	5 (.38%)
Hyperbilirubinaemia	5 (.38%)
Leukocytoclastic Vasculitis	5 (.38%)
Melaena	5 (.38%)
Memory Impairment	5 (.38%)
Renal Impairment	5 (.38%)
Restless Legs Syndrome	5 (.38%)
Sleep Apnoea Syndrome	5 (.38%)
Acute Hepatic Failure	4 (.3%)
Amnesia	4 (.3%)
Coma	4 (.3%)
Drug Ineffective	4 (.3%)
Eosinophilia	4 (.3%)
Gastrooesophageal Reflux Disease	4 (.3%)
Hepatic Necrosis	4 (.3%)
Hepatitis Acute	4 (.3%)
Hepatorenal Syndrome	4 (.3%)
Hyperkalaemia	4 (.3%)
Immune System Disorder	4 (.3%)
Insomnia	4 (.3%)
International Normalised Ratio Incr...	4 (.3%)
Lactic Acidosis	4 (.3%)
Lip Disorder	4 (.3%)
Multi-organ Failure	4 (.3%)
Neutropenia	4 (.3%)
Peripheral Sensory Neuropathy	4 (.3%)
Pulmonary Embolism	4 (.3%)
Skin Fissures	4 (.3%)
Somnolence	4 (.3%)
Vertigo	4 (.3%)
Abdominal Pain Upper	3 (.23%)
Activities Of Daily Living Impaired	3 (.23%)
Anaemia	3 (.23%)
Aphonia	3 (.23%)
Ataxia	3 (.23%)
Axonal Neuropathy	3 (.23%)
Biliary Cirrhosis Primary	3 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ezetrol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ezetrol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ezetrol

What are the most common Ezetrol adverse events reported to the FDA?

Neurological	121 (9.22%)
Cardiac Arrhythmias	85 (6.47%)
Muscle	77 (5.86%)
Respiratory	65 (4.95%)
Cardiac And Vascular Investigations	62 (4.72%)
Hepatic And Hepatobiliary	55 (4.19%)
Hepatobiliary	55 (4.19%)
Gastrointestinal Signs	46 (3.5%)
Enzyme	44 (3.35%)
Renal Disorders	26 (1.98%)
Myocardial	25 (1.9%)
	Show More
Oral Soft Tissue Conditions	22 (1.68%)
Cranial Nerve Disorders	21 (1.6%)
Epidermal And Dermal Conditions	20 (1.52%)
Therapeutic And Nontherapeutic Effe...	20 (1.52%)
Infections - Pathogen Unspecified	19 (1.45%)
Tongue Conditions	17 (1.29%)
Lipid Analyses	13 (.99%)
Eye	12 (.91%)
Injuries	12 (.91%)
Joint	11 (.84%)
Renal And Urinary Tract Investigati...	11 (.84%)
Skin Vascular Abnormalities	11 (.84%)
Body Temperature Conditions	10 (.76%)
Encephalopathies	10 (.76%)
Peripheral Neuropathies	10 (.76%)
White Blood Cell	10 (.76%)
Dissociative	9 (.69%)
Lower Respiratory Tract Disorders	9 (.69%)
Mental Impairment	9 (.69%)
Musculoskeletal And Connective Tiss...	9 (.69%)
Ocular Infections, Irritations And ...	9 (.69%)
Protein And Chemistry Analyses	9 (.69%)
Electrolyte And Fluid Balance Condi...	8 (.61%)
Fatal Outcomes	8 (.61%)
Gastrointestinal Hemorrhages	7 (.53%)
Heart Failures	7 (.53%)
Acid-base	6 (.46%)
Allergic Conditions	6 (.46%)
Bacterial Infectious	6 (.46%)
Exocrine Pancreas Conditions	6 (.46%)
Hematology Investigations	6 (.46%)
Lifestyle Issues	6 (.46%)
Physical Examination Topics	6 (.46%)
Anemias Nonhemolytic And Marrow Dep...	5 (.38%)
Disturbances In Thinking	5 (.38%)
Gastrointestinal Motility And Defec...	5 (.38%)
Pulmonary Vascular	5 (.38%)
Sleep Disorders	5 (.38%)
Bone And Joint Injuries	4 (.3%)
Cardiac Disorder Signs	4 (.3%)
Decreased And Nonspecific Blood Pre...	4 (.3%)
Gastrointestinal Inflammatory Condi...	4 (.3%)
Immune	4 (.3%)
Inner Ear And Viiith Cranial Nerve	4 (.3%)
Neuromuscular	4 (.3%)
Appetite And General Nutritional	3 (.23%)
Arteriosclerosis, Stenosis, Vascula...	3 (.23%)
Autoimmune	3 (.23%)
Coagulopathies And Bleeding Diathes...	3 (.23%)
Skin Appendage Conditions	3 (.23%)
Urinary Tract Signs	3 (.23%)
Vision	3 (.23%)
Abdominal Hernias And Other Abdomin...	2 (.15%)
Benign Neoplasms Gastrointestinal	2 (.15%)
Connective Tissue Disorders	2 (.15%)
Coronary Artery	2 (.15%)
Deliria	2 (.15%)
Depressed Mood Disorders	2 (.15%)
Gastrointestinal Neoplasms Malignan...	2 (.15%)
Gastrointestinal Stenosis And Obstr...	2 (.15%)
Gastrointestinal Therapeutic Proced...	2 (.15%)
Gastrointestinal Ulceration And Per...	2 (.15%)
Headaches	2 (.15%)
Iron And Trace Metal Metabolism	2 (.15%)
Lymphomas	2 (.15%)
Movement Disorders	2 (.15%)
Procedural And Device Related Injur...	2 (.15%)
Viral Infectious	2 (.15%)
Water, Electrolyte And Mineral	2 (.15%)
Anxiety Disorders	1 (.08%)
Bone Disorders	1 (.08%)
Bone, Calcium, Magnesium And Phosph...	1 (.08%)
Bronchial Disorders	1 (.08%)
Changes In Physical Activity	1 (.08%)
Gallbladder	1 (.08%)
Gastrointestinal	1 (.08%)
Glucose Metabolism Disorders	1 (.08%)
Hearing	1 (.08%)
Lipid Metabolism	1 (.08%)
Medication Errors	1 (.08%)
Miscellaneous And Site Unspecified ...	1 (.08%)
Mycoplasmal Infectious	1 (.08%)
Neoplasm Related Morbidities	1 (.08%)
Nephropathies	1 (.08%)
Ocular Structural Change, Deposit A...	1 (.08%)
Purine And Pyrimidine Metabolism	1 (.08%)
Reproductive Neoplasms Male Maligna...	1 (.08%)
Salivary Gland Conditions	1 (.08%)
Seizures	1 (.08%)
Sleep Disturbances	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ezetrol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ezetrol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.